Developing new cancer treatment tools, using imaging techniques such as PET-CT and MRI, and new radiopharmaceuticals for next-generation personalized therapies (“Theranostics”) to target cancer first at the “diagnosis” phase and then at the “therapy” phase, using the same biological targets (“see to treat”).
Medtronic hires neuromodulation president from Smith+Nephew
Name: Paolo Di Vincenzo New title: President of neuromodulation at Medtronic Previous title: Senior vice president and general manager of U.S. advanced wound management at
October 5, 2023